Noom

GLP-1s are still one of the hottest topics in healthcare. Thanks to Wei-Li Shao, Vanessa Rissetto, MS, RD, CDN, and Anjalee Khemlani for including us in a lively discussion around the benefits and challenges of direct-to-consumer prescribing models, increased access and affordability of GLP-1s. As our own Cody Fair said, “We believe in them. And we believe they can be life changing.” #ViVE25 #ViVEevent #GLP1s #Healthcare

Behavior change is the cornerstone of building healthier, sustainable habits that reduce the risks of chronic disease and obesity. Yet most people don’t have the tools to develop these types of changes on their own. This is the crux of a successful behavior change program, and what Noom’s 4-Cs are set up to do. Our clinicians, coaches, community, and content are at the heart of our behavior change approach, enhancing engagement and providing actionable strategies for long-term behavior change that ultimately drive better outcomes and cost savings. Our latest blog post dives into each of these components and how Noom is uniquely positioned to support organizations in helping their populations achieve long-term health, no matter where they are on their journey 👉 https://lnkd.in/ee8nwcSr #HRInsights #EmployeeWellness #ChronicDiseasePrevention #BehaviorChange

🎉Noom Health is going to ViVE this year in Nashville, TN! Stop by the Country Stage to hear from Noom’s Chief Commercial Officer Cody Fair as he delves into the risk and viability of prescribing GLP-1s. See you there!

Noom CEO Geoff Cook is taking the stage at #SXSW 2025 on March 8 at 2:30 PM CT to cut through the social media noise surrounding GLP-1s. 🩺 As a leader in accessible GLP-1s, Noom is shaping the future of weight loss through its behavior change approach. Geoff will join industry experts to unpack what truly needs to change to build a more effective, sustainable healthcare system. Don’t miss this important conversation: bit.ly/Noom-SXSW

🎉Meet us in St. Pete Beach! Noom will be attending the Health Benefits Conference & Expo this year  –  stop by Booth 206 with Michael Sweetser to hear how Noom can help you offer effective health and wellness benefits for your organization. Get the tools you need to demonstrate the value of your health and wellness benefits, lower costs, and much more at HBCE. See you there!

The nationwide GLP-1 shortage has been a key topic in healthcare since late 2022. Compounding provided a temporary solution for Americans unable to access or afford branded GLP-1s, but the future of these alternatives is now uncertain. As the production of branded GLP-1s ramps up, questions loom about the ability of all Americans to continue to have fair and equitable access to these life-changing medications. Check out our latest blog for insights into the evolving GLP-1 landscape and what the end of the shortage really means. 👉 https://lnkd.in/dvWTRhN6 #GLP1 #HealthcareInsights #AffordableCare #HealthEquity #Wellness

📣 Noom just launched 2 FREE features to help you track progress, understand your body, and stay motivated: 1. AI Body Scan – In just 10 seconds, use your smartphone camera to generate a personalized 3D model of your body, helping you track changes over time. 2. Noom Body Age Prediction – Get an estimate of your biological body age based on key health factors and see what small changes can help you feel healthier. Wellness should be accessible to everyone! 💪 Learn more: https://lnkd.in/gQue-XqC

🚨ATTN: Noom is going to the NEEBC for Innovation in Employee Benefits: Changing the Game this year! Join Noom’s Michael Sweetser and Jackie Johnson, CEBS, as we learn all things employee benefits and total rewards for professionals in New England and beyond. Come advance your knowledge and network with fellow employee benefits and rewards practitioners, consultants, and providers of services with Noom!

🩺 How is Noom shaping the future of digital healthcare? Noom's GLP-1 Companion just got a major upgrade in Preparation for the Newly Expected Prescription Drug Use-Related Software (PDURS) Model, including new features like our AI-driven Welli Meal Planner and Dynamic Calorie Goals, all designed to enhance wellness outcomes. Read more about it:

Glad to see POLITICO's coverage of Noom's newest GLP-1 Companion update.. "The weight-loss platform Noom is rolling out a software update Monday that it says could be a model for the FDA to consider as drug companies look to software add-ons to their labels to encourage medication adherence for GLP-1s. "We believe that there's going to be kind of a gold rush toward these digital solutions - not just in GLP-1s ..." Cook told POLITICO ahead of the announcement. "The fundamental thing here is Pharma companies are going to be looking for different ways to distinguish themselves in a crowded market." Why it matters: The draft framework essentially allows a firm to conduct cheaper Phase IV studies of a software companion when a drug is already on the market, rather than randomly controlled Phase III trials in which the medicine and app are evaluated together. If the guidance is finalized, it will give companies like Noom the opportunity to be the platform of choice for drug-software combination products, Cook said, even beyond weight-loss drugs. "We're positioning for a future where every GLP-1 - every pharmaceutical company with a GLP-1 - is going to have a PDURS solution paired with it," he said."